A business review by IXICO’s CEO, Giulio Cerroni, refined the company’s value proposition while maintaining its intent to scale the business and diversify within neuroscience. IXICO is evolving from being a medical imaging expert into being a data analytics company focused on providing tech services to pharma mainly in neuroscience. In Vivo shares how the CEO has restructured leadership to encourage more partnerships and accelerate growth and how IXICO’s actions could help it realize its ambition to exploit artificial intelligence and digital markers to help pharma crack some of the most persistent therapeutic challenges.